CompletedPhase 2ketamine

Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)

Sponsored by New York State Psychiatric Institute

NCT ID
NCT01100255
Target Enrollment
15 participants
Start Date
2010-04
Est. Completion
2015-12

About This Study

In this study investigators are studying the effects of a drug called ketamine on the symptoms of Obsessive-compulsive disorder (OCD).

Conditions Studied

Obsessive-Compulsive Disorder

Interventions

  • •Ketamine infusion
  • •Saline

Eligibility

Age:18 Years - 55 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Age 18-55
* Physically healthy and not currently pregnant
* Primary Diagnosis of OCD
* Sufficient severity of symptoms
* Able to provide consent

Exclusion Criteria:

* Psychiatric conditions that make participation unsafe
* Currently on psychotropic medication
* Medical conditions that make participation unsafe
* Allergy to ketamine
* Any metal in the body

Study Locations (1)

New York State Psychiatric Institute
New York, New York, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD) | Huxley